✦ LIBER ✦

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial

✍ Scribed by Deutsch, E.; Lemanski, C.; Pignon, J. P.; Levy, A.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Paris, E.; Juzyna, B.; Ezra, P.; Azria, D.

Book ID: 121693422
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 102 KB
Volume: 24
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt368

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel–carboplatin chemotherapy combi

Docetaxel–carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)—Results of the nonrandomised phase II study TaxErb

✍ Fischer, J.R.; Griesinger, F.; Fink, T.; Salm, T.; Marseille, A.; Wolf, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 271 KB

1084 Interim results of a phase II trial

1084 Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)

✍ Zalcberg, J.R.; Bishop, J.F.; Millward, M.J.; Zimet, A.; Laird, J.; Barter, C.; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB

583 Induction Chemotherapy with Docetaxe

583 Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Head and Neck Cancer. Preliminary Results of a Phase I/II Study

✍ Perri, F.; Muto, P.; Schiavone, C.; Ionna, F.; Aversa, C.; Maiolino, P.; Cavalca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Meta-analysis of Toxicities in Phase I o

Meta-analysis of Toxicities in Phase I or II Trials Studying the Use of Target Therapy (TT) Combined With Radiation Therapy in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)

✍ Santos, M.; Lefeuvre, D.; Le Teuff, G.; Bourgier, C.; Le Pechoux, C.; Soria, J.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

8533 POSTER First Results of an Uncontro

8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

✍ Remenar, E.; Lövey, J.; Koltai, P.; Horvath, K.; Gödeny, M.; Kasler, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

PD-039 A phase II study of cetuximab (C2

PD-039 A phase II study of cetuximab (C225) in combination withchemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial

✍ Blumenschein, G.; Swann, S.; Curran, W.; Robert, F.; Werner Wasik, M.; Jafar, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 124 KB